Alcolase raises €1.5M to tackle alcohol intolerance with enzyme technology

Danish biotech startup Alcolase has raised €1.5 million with investment from Ada Ventures, Delphinus Venture Capital, Antler, Manigoff Invest and a group of business angels. Alcolase is developing an enzyme-based technology designed to break down alcohol in the stomach before it is absorbed into the bloodstream. The technology is aimed at approximately 540 million people in East Asia living with ALDH2 deficiency, a genetic variant that makes it difficult for the body to break down alcohol effect